New precision medicine venture gives Syngenis added firepower
Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.
Depository of News
Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.